Related Experiment Video
Updated: May 28, 2026
09:15
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Transplant glomerulopathy: it's not always about chronic rejection
Kidney International
|October 1, 2011
Summary
Transplant glomerulopathy (TG), a kidney transplant lesion, can indicate chronic antibody-mediated rejection (AMR). However, TG may also stem from other conditions like hepatitis C or thrombotic microangiopathy.
Area of Science:
- Nephrology
- Transplantation Immunology
- Pathology
Background:
- Transplant glomerulopathy (TG) is a key indicator of chronic antibody-mediated rejection (AMR) in renal allografts.
- TG is defined by glomerular basement membrane duplication in kidney transplants.
- The current understanding of TG primarily links it to chronic AMR.
Discussion:
- TG's diagnostic specificity is limited, as it can arise from various endothelial injuries.
- Alternative causes of TG include hepatitis C infection and thrombotic microangiopathy.
- These conditions, alongside chronic AMR, can manifest as TG, highlighting diagnostic challenges.
Key Insights:
- Transplant glomerulopathy is not exclusively caused by chronic antibody-mediated rejection.
- Hepatitis C and thrombotic microangiopathy are significant differential diagnoses for TG.
- Understanding these diverse etiologies is crucial for accurate diagnosis and management.
Outlook:
- Further research is needed to differentiate TG causes effectively.
- Developing specific biomarkers for TG subtypes could improve patient outcomes.
- This nuanced understanding will refine treatment strategies for kidney transplant recipients.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:40Cell-mediated Immune Responses
Overview